Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Share-based Compensation (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Share-based Compensation for 5 consecutive years, with $555000.0 as the latest value for Q4 2020.

  • Quarterly Share-based Compensation rose 1690.32% to $555000.0 in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $956000.0 through Dec 2020, down 53.0% year-over-year, with the annual reading at $6.3 million for FY2025, 102.2% up from the prior year.
  • Share-based Compensation for Q4 2020 was $555000.0 at Forte Biosciences, up from $375000.0 in the prior quarter.
  • The five-year high for Share-based Compensation was $2.0 million in Q1 2019, with the low at $1000.0 in Q2 2019.
  • Average Share-based Compensation over 5 years is $781700.0, with a median of $466000.0 recorded in 2016.
  • The sharpest move saw Share-based Compensation crashed 99.94% in 2019, then surged 18650.0% in 2020.
  • Over 5 years, Share-based Compensation stood at $403000.0 in 2016, then soared by 241.19% to $1.4 million in 2017, then grew by 27.27% to $1.8 million in 2018, then tumbled by 98.23% to $31000.0 in 2019, then soared by 1690.32% to $555000.0 in 2020.
  • According to Business Quant data, Share-based Compensation over the past three periods came in at $555000.0, $375000.0, and $24000.0 for Q4 2020, Q3 2020, and Q2 2020 respectively.